Dr. Mayako Michino
Mayako Michino is an experienced computational chemist and drug designer. Prior to Manas, she was at a non-profit biotech in NYC, where she made key contributions to advancing small molecule preclinical drug discovery programs across a range of therapeutic targets and disease areas. She serves as the Director in Computational Chemistry for Manas AI.
Mayako Michino, Ph.D. joined Manas AI in 2025 as Director in Computational Chemistry. Previously, Mayako was Senior Associate Director in Computational Chemistry at the non-profit biotech Tri-Institutional Therapeutics Discovery Institute (TDI), where she made key contributions in advancing TDI’s early-stage drug discovery programs, from hit identification to lead optimization. She has over 10 years of experience as a computational drug design scientist in preclinical drug discovery, and has worked with diverse therapeutic targets and disease areas.
She is trained in computational biophysics and molecular modeling for applications in drug discovery. She obtained a PhD from The Scripps Research Institute, and completed postdoctoral training at Weill Cornell Medicine.